Page last updated: 2024-10-27

fluconazole and Blastomyces brasiliensis Infection

fluconazole has been researched along with Blastomyces brasiliensis Infection in 15 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Eighty-eight immunocompetent patients with deep mycoses from eight countries were evaluated with the same protocol for efficacy of fluconazole monotherapy."9.07A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. ( Arathoon, EG; Borelli, D; Bran, JL; Castro, LG; Diaz, M; Franco, L; Montero-Gei, F; Negroni, R; Restrepo, A; Sampaio, SA, 1992)
"Eighty-eight immunocompetent patients with deep mycoses from eight countries were evaluated with the same protocol for efficacy of fluconazole monotherapy."5.07A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. ( Arathoon, EG; Borelli, D; Bran, JL; Castro, LG; Diaz, M; Franco, L; Montero-Gei, F; Negroni, R; Restrepo, A; Sampaio, SA, 1992)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (40.00)18.2507
2000's4 (26.67)29.6817
2010's5 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lino, CI1
Gonçalves de Souza, I1
Borelli, BM1
Silvério Matos, TT1
Santos Teixeira, IN1
Ramos, JP1
Maria de Souza Fagundes, E1
de Oliveira Fernandes, P1
Maltarollo, VG1
Johann, S1
de Oliveira, RB1
Morais, EA1
Martins, EM4
Boelone, JN1
Gomes, DA1
Goes, AM4
Fernandes, VC3
Boeloni, JN3
Coitinho, JB2
Serakides, R3
Kurita, N1
Brummer, E1
Oarada, M1
Miyaji, M1
Ginarte, M1
Pereiro, M3
Toribio, J2
Yasuda, MA1
de Moura, LP1
Raffin, CN1
del Negro, GM2
Ferreira, MS1
García García, A1
Kawayama, T1
Sawa, A1
Sueyasu, Y1
Arikawa, K1
Shiraishi, T1
Ichikawa, Y1
Oizumi, K1
Souza, AR1
Gesztesi, JL1
Benard, G1
Sato, J1
Santos, MV1
Abrahão, TB1
Lopes, JD1
Martinez, R1
Malta, MH1
Verceze, AV1
Arantes, MR1
Diaz, M1
Negroni, R1
Montero-Gei, F1
Castro, LG1
Sampaio, SA1
Borelli, D1
Restrepo, A1
Franco, L1
Bran, JL1
Arathoon, EG1

Reviews

1 review available for fluconazole and Blastomyces brasiliensis Infection

ArticleYear
Pharmacological management of paracoccidioidomycosis.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:3

    Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up St

2005

Trials

1 trial available for fluconazole and Blastomyces brasiliensis Infection

ArticleYear
A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14 Suppl 1

    Topics: Adolescent; Adult; Aged; Chromoblastomycosis; Coccidioidomycosis; Female; Fluconazole; Fungi; Histop

1992

Other Studies

13 other studies available for fluconazole and Blastomyces brasiliensis Infection

ArticleYear
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbi

2018
Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.
    Mycopathologia, 2015, Volume: 179, Issue:1-2

    Topics: Animals; Antifungal Agents; Antigens, Fungal; Caspase 3; Collagen; Fluconazole; Fungal Proteins; Fun

2015
Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis.
    PloS one, 2011, Mar-10, Volume: 6, Issue:3

    Topics: Animals; Antifungal Agents; Antigens, Fungal; Cloning, Molecular; Colony-Forming Units Assay; Flucon

2011
The combined use of Paracoccidioides brasiliensis Pb40 and Pb27 recombinant proteins enhances chemotherapy effects in experimental paracoccidioidomycosis.
    Microbes and infection, 2011, Volume: 13, Issue:12-13

    Topics: Adjuvants, Immunologic; Animals; Antifungal Agents; Antigens, Fungal; Combined Modality Therapy; Cyt

2011
Protective effect of rPb40 as an adjuvant for chemotherapy in experimental paracoccidioidomycosis.
    Mycopathologia, 2012, Volume: 174, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Drug Thera

2012
Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
    Medical mycology, 2003, Volume: 41, Issue:2

    Topics: Antifungal Agents; Drug Synergism; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Hu

2003
Imported paracoccidioidomycosis in Spain.
    Mycoses, 2003, Volume: 46, Issue:9-10

    Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Male; Paracoccidioides; Paracoccidioidom

2003
[Paracoccidioidomycosis evidencing spinal cord involvement treated with success by fluconazole].
    Arquivos de neuro-psiquiatria, 1994, Volume: 52, Issue:1

    Topics: Fluconazole; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myelitis, Transverse; Paracoccid

1994
Immunological features of chronic adult paracoccidioidomycosis: report of a case treated with fluconazole.
    Acta dermato-venereologica, 1996, Volume: 76, Issue:1

    Topics: Aged; Antifungal Agents; Chronic Disease; Fluconazole; Humans; Male; Paracoccidioides; Paracoccidioi

1996
[Chronic pulmonary paracoccidioidomyosis in a Japanese Adult].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34, Issue:8

    Topics: Antifungal Agents; Chronic Disease; Fluconazole; Humans; Lung Diseases, Fungal; Male; Middle Aged; P

1996
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1997, Sep-12, Volume: 39, Issue:1009

    Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom

1997
Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis.
    Clinical and diagnostic laboratory immunology, 2000, Volume: 7, Issue:2

    Topics: Adult; Animals; Antibodies, Anti-Idiotypic; Antibodies, Fungal; Antibodies, Monoclonal; Antifungal A

2000
Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat.
    Mycopathologia, 1999, Volume: 146, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Humans; Pa

1999